Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI eye check: could DRISTi replace human screenings for diabetic retinopathy?

NCT ID NCT07222293

Recruiting now Diagnosis Sponsor: Artelus AI Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study checks if an AI software named DRISTi can accurately detect diabetic retinopathy, a serious eye disease, in people with diabetes. About 900 participants will have their eye images analyzed by both DRISTi and a human reading center. The goal is to see if the AI matches human experts, potentially making screening faster and more accessible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY (DR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetes mellitus diabetic retinopathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC RETINOPATHY (DR)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • New Century Ophthalmology - Oxford

    RECRUITING

    Oxford, North Carolina, 27565, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • New Century Ophthalmology - Raleigh

    RECRUITING

    Raleigh, North Carolina, 27617, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.